Paul M Wilkerson

Synthetic lethality of PARP inhibition in cancers lacking<i>BRCA1</i>and<i>BRCA2</i>mutations

Konstantin J. Dedes, Paul M Wilkerson, Daniel Wetterskog et al. · Cell Cycle · 2011 · 192 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Genomic and mutational profiling of ductal carcinomas <i>in situ</i> and matched adjacent invasive breast cancers reveals intra‐tumour genetic heterogeneity and clonal selection

Lucía Hernández, Paul M Wilkerson, Maryou B. Lambros et al. · The Journal of Pathology · 2012 · 152 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification

Charlotte K.Y. Ng, Luciano G. Martelotto, Arnaud Gauthier et al. · Genome Biology · 2015 · 136 citations · Full text

Medicine, Genetics, Oncology +16

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast

Rachael Natrajan, Paul M Wilkerson, Caterina Marchiò et al. · The Journal of Pathology · 2014 · 105 citations · Full text

Medicine, Genetics, Oncology +17

Immunophenotypic and genomic characterization of papillary carcinomas of the breast

Raphaëlle Duprez, Paul M Wilkerson, Magali Lacroix‐Triki et al. · The Journal of Pathology · 2011 · 102 citations

Medicine, Oncology, Pathology +17